+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emphysema Treatment Market by Treatment Type, Drug Class, Therapy Line, Route of Administration, Dosage Form, Distribution Channel, Product Type - Global Forecast to 2030- Product Image
Emphysema Treatment Market by Treatment Type, Drug Class, Therapy Line, Route of Administration, Dosage Form, Distribution Channel, Product Type - Global Forecast to 2030- Product Image
Sale

Emphysema Treatment Market by Treatment Type, Drug Class, Therapy Line, Route of Administration, Dosage Form, Distribution Channel, Product Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015346
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Emphysema Treatment Market is evolving rapidly as precision medicine, advanced therapies, and digital innovation redefine patient care and value creation for healthcare stakeholders. Senior decision-makers seeking growth opportunities in respiratory therapies will benefit from actionable insights into market segmentation, leading technologies, and evolving global demand.

Market Snapshot: Emphysema Treatment Market Overview

Global demand for emphysema therapeutics is driven by the rising prevalence of chronic obstructive pulmonary disease and increasing adoption of cutting-edge treatments. The market grew from USD 6.83 billion in 2024 to USD 7.32 billion in 2025. It is expected to follow a compound annual growth rate (CAGR) of 7.04%, reaching USD 10.28 billion by 2030. Strategic investments in inhalation technologies, biologics, and minimally invasive surgical procedures continue to define the industry landscape, with regions such as Asia-Pacific and the Americas at the forefront of innovation and adoption. The introduction of targeted therapies and digital health tools is fostering decentralized models of care, further supporting market expansion.

Scope & Segmentation

This report delivers a comprehensive analysis across therapeutic approaches, drug classes, care stages, and key geographical areas:

  • Treatment Types: Covers pharmacological therapies—antibiotics, bronchodilators, corticosteroids, mucolytics—and surgical options including bullectomy, lung transplantation, lung volume reduction surgery, and valve therapy.
  • Drug Classes: Examines anticholinergics, beta-agonists, and combination drugs, each offering varied mechanisms and safety profiles.
  • Therapy Lines: Considers adjunctive, first-line, maintenance, and rescue interventions addressing disease progression and acute symptom management.
  • Routes of Administration: Incorporates inhalation (dry powder, metered dose, nebulizer, soft mist), intravenous infusion and injection, as well as oral forms (capsule, solution, tablet).
  • Dosage Forms: Includes capsules, inhalers, nebulizers, solutions, and tablets, aligning with patient preferences and device compatibility.
  • Distribution Channels: Encompasses hospital, online, and retail pharmacy networks, each with unique access and margin characteristics.
  • Product Types: Delineates brand and generic products, highlighting dynamics influenced by patent expiries, pricing, and biosimilar entry.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, UAE, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, and key economies).
  • Company Developments: Features significant initiatives from leading players such as GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, AstraZeneca plc, Novartis AG, Teva Pharmaceutical Industries Ltd, Viatris Inc., Chiesi Farmaceutici S.p.A., Sunovion Pharmaceuticals Inc., Sandoz International GmbH, and Cipla Limited.

Key Takeaways for Strategic Decision-Makers

  • Innovative inhalation devices and digital health platforms are enhancing patient adherence and remote care management, quickly becoming integrated into clinical pathways.
  • Growing collaborations between biotech and tech firms are accelerating the pipeline for biologics, cell-based therapies, and artificial intelligence-driven diagnostics.
  • Minimally invasive surgical advancements are expanding treatment options for advanced emphysema, offering alternatives to conventional surgery and improving patient recovery experiences.
  • Value-based care models and outcome-based reimbursement frameworks are gaining traction, encouraging stakeholders to link clinical efficacy with payment strategies.
  • Regional disparities in treatment access, regulatory policies, and reimbursement structures influence local adoption rates, emphasizing the importance of tailored market entry and expansion strategies.
  • Brand-generic competition is intensifying, especially in cost-sensitive markets, as biosimilar and generic manufacturers increase market participation.

Tariff Impact on Accessibility and Supply Chain

Tariff measures introduced in the United States are affecting global supply chains and procurement processes for pharmaceuticals and device components. Many manufacturers are shifting toward localized production or exploring alternative supplier agreements to counteract elevated import duties. Device makers have adjusted distributor relationships or absorbed increased costs to retain competitive pricing, while providers and payers intensify value assessment and reimbursement negotiations. These dynamics underscore how cost structures can shift rapidly in response to trade policy changes, compelling companies to pursue integrated and outcome-based service offerings.

Methodology & Data Sources

The analysis is anchored in extensive primary research, with structured interviews conducted among pulmonologists, surgeons, payers, and procurement experts. Proprietary surveys provided further quantitative validation, and secondary sources included peer-reviewed literature and regulatory databases. All findings underwent triangulation and multi-stage expert review to deliver a reliable synthesis supporting market forecasts and trend analysis.

Why This Report Matters

  • Enables leadership teams to navigate evolving competitive landscapes and regulatory changes with confidence.
  • Supports investment decisions by identifying high-growth segments and evaluating the impact of technology adoption and reimbursement models.
  • Equips stakeholders with actionable intelligence to adapt strategies for supply chain resilience, patient engagement, and partnership development.

Conclusion

The future of the Emphysema Treatment Market will be shaped by digital convergence, therapeutic innovation, and agile supply chain management. Companies positioned to align clinical advancement with adaptive strategies will lead in delivering improved patient outcomes and sustainable market growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Emphysema Treatment Market, by Treatment Type
8.1. Introduction
8.2. Pharmacological
8.2.1. Antibiotics
8.2.2. Bronchodilators
8.2.3. Corticosteroids
8.2.4. Mucolytics
8.3. Surgical
8.3.1. Bullectomy
8.3.2. Lung Transplantation
8.3.3. Lung Volume Reduction Surgery
8.3.4. Valve Therapy
9. Emphysema Treatment Market, by Drug Class
9.1. Introduction
9.2. Anticholinergics
9.3. Beta-Agonists
9.4. Combination Drugs
10. Emphysema Treatment Market, by Therapy Line
10.1. Introduction
10.2. Adjunctive
10.3. First-Line
10.4. Maintenance
10.4.1. Combination Therapy
10.4.2. Long-Acting Anticholinergics
10.4.3. Long-Acting Beta-Agonists
10.5. Rescue
10.5.1. Short-Acting Anticholinergics
10.5.2. Short-Acting Beta-Agonists
11. Emphysema Treatment Market, by Route of Administration
11.1. Introduction
11.2. Inhalation
11.2.1. Dry Powder Inhaler
11.2.2. Metered Dose Inhaler
11.2.3. Nebulizer
11.2.4. Soft Mist Inhaler
11.3. Intravenous
11.3.1. Infusion
11.3.2. Injection
11.4. Oral
11.4.1. Capsule
11.4.2. Solution
11.4.3. Tablet
12. Emphysema Treatment Market, by Dosage Form
12.1. Introduction
12.2. Capsule
12.3. Inhaler
12.4. Nebulizer
12.5. Solution
12.6. Tablet
13. Emphysema Treatment Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacy
13.3. Online Pharmacy
13.4. Retail Pharmacy
14. Emphysema Treatment Market, by Product Type
14.1. Introduction
14.2. Brand
14.3. Generic
15. Americas Emphysema Treatment Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Emphysema Treatment Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Emphysema Treatment Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. GlaxoSmithKline plc
18.3.2. Boehringer Ingelheim International GmbH
18.3.3. AstraZeneca plc
18.3.4. Novartis AG
18.3.5. Teva Pharmaceutical Industries Ltd
18.3.6. Viatris Inc.
18.3.7. Chiesi Farmaceutici S.p.A.
18.3.8. Sunovion Pharmaceuticals Inc.
18.3.9. Sandoz International GmbH
18.3.10. Cipla Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. EMPHYSEMA TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. EMPHYSEMA TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. EMPHYSEMA TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EMPHYSEMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. EMPHYSEMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. EMPHYSEMA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BULLECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG VOLUME REDUCTION SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY VALVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BETA-AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ADJUNCTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY FIRST-LINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING BETA-AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING BETA-AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRAND, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 94. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 96. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 97. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 98. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 99. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 100. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 101. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 103. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 104. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 105. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 110. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 111. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 113. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 115. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 117. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 119. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 120. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 181. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 182. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 183. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 184. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 188. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 190. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 191. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 194. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 195. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 196. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 197. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 198. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 199. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 202. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 204. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 205. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 223. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 224. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 225. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 226. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 227. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 228. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 230. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 231. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 232. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 233. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 236. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 237. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 238. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 239. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 240. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 241. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 242. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 244. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 245. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 246. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 247. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. SPAIN EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 292. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 293. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 294. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 295. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 296. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 297. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 298. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 299. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 300. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 301. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 302. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 303. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 310. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 311. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 312. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 313. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 314. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 315. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 316. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 320. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 321. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 322. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 323. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 324. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 325. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 326. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 328. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 329. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 330. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 331. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. QATAR EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 334. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2030 (USD MILLION)
TABLE 335. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 336. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 337. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2030 (USD MILLION)
TABLE 338. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2030 (USD MILLION)
TABLE 339. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2030 (USD MILLION)
TABLE 340. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 341. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 342. FINLAND EMPHYSEMA TREATMENT MARKET S

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Emphysema Treatment market report include:
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • AstraZeneca plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Chiesi Farmaceutici S.p.A.
  • Sunovion Pharmaceuticals Inc.
  • Sandoz International GmbH
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.28 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Emphysema Treatment Market Report 2025 - Product Image

Emphysema Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Emphysema Treatment Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034) - Product Image

Emphysema Treatment Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Emphysema Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Emphysema Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Emphysema Treatment Medication Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Emphysema Treatment Medication Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Emphysema Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Emphysema Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From

About the Emphysema Drug Market

The Emphysema Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat emphysema, a chronic lung disease that causes shortness of breath, coughing, and wheezing. These drugs are typically inhaled corticosteroids, bronchodilators, and phosphodiesterase-4 inhibitors. They are used to reduce inflammation, open airways, and improve breathing. The Emphysema Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Boehringer Ingelheim. Other companies, such as Sunovion, Teva Pharmaceuticals, and Mylan, also offer products in this market. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.